We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; ba... Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. Show more
U.S. index futures displayed positive performance in pre-market trading on Wednesday, with S&P 500 aiming to halt a downward trend that persisted over the last three consecutive days. As of...
Stocks showed a lack of direction over the course of the trading day on Tuesday, as traders took a breather following the sell-off seen over the two previous sessions. The major averages bounced...
2024 First-Quarter reported sales growth of 2.3% to $21.4 Billion with operational growth of 3.9%* and adjusted operational growth of 4.0%* Adjusted operational growth excluding COVID-19 Vaccine...
Johnson & Johnson (NYSE:JNJ) reported a robust start to fiscal 2024, with a 2.3% increase in first-quarter sales, reaching $21.4 billion. This financial uptick comes after the company’s...
The major U.S. index futures are currently pointing to higher open on Tuesday, with stocks likely to regain ground after moving sharply lower over the two previous sessions. Bargain hunting may...
U.S. index futures are mixed in pre-market trading this Tuesday, with the Dow Jones aiming to break a six-day losing streak. At 6:26 AM, the Dow Jones futures (DOWI:DJI) were up 65 points, or...
Live Nation Entertainment (NYSE:LYV) – The U.S. Department of Justice plans to initiate an antitrust lawsuit against Live Nation next month, citing its control over the live event market...
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd...
2024 First-Quarter reported sales growth of 2.3% to $21.4 Billion with operational growth of 3.9%* and adjusted operational growth of 4.0%* Adjusted operational growth excluding COVID-19 Vaccine...
Following the steep drop seen last Friday, stocks showed another substantial move to the downside over the course of the trading session on Monday. The major averages moved notably higher early...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.27 | -1.53368015675 | 148.01 | 149.49 | 143.13 | 9254344 | 145.83749409 | CS |
4 | -9.95 | -6.39090500353 | 155.69 | 159.14 | 143.13 | 7546898 | 151.49526696 | CS |
12 | -14.69 | -9.1566415259 | 160.43 | 163.11 | 143.13 | 7434995 | 156.24146324 | CS |
26 | -5.93 | -3.90980418013 | 151.67 | 163.58 | 143.13 | 7100991 | 155.41105758 | CS |
52 | -16.58 | -10.2143913258 | 162.32 | 175.97 | 143.13 | 10964864 | 162.8920685 | CS |
156 | -16.7 | -10.2807190347 | 162.44 | 186.69 | 143.13 | 8432817 | 166.10462796 | CS |
260 | 8.32 | 6.05443166933 | 137.42 | 186.69 | 109.16 | 8149036 | 157.53657472 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions